News
(2)April 2026
Nuvation Bio Inc. — ARS Filing
# 🧾 What This Document Is This is Nuvation Bio's **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "check-in" with its owners (the shareholders). It's a comprehensive report that combines financial data, business highlights, and future plans into one document, going beyo
NUVB Sets 2026 Annual Vote on Three Director Nominees
# 🧾 What This Document Is This is Nuvation Bio’s **DEF 14A Proxy Statement**, a formal invitation and explanation for its **2026 Annual Meeting of Stockholders**. It outlines proposals for shareholder votes, details on director nominees, executive compensation, and governance practices. Sharehold
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.